Person

Roeland Nusse

Formerly Director, Bio-Techne

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$8.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 25, 2025TECHSale17,040$56.36$960K
Mar 7, 2024TECHSale10,400$76.98$801K
Aug 30, 2023TECHSale8,939$80.32$718K
Aug 23, 2021TECHSale4,000$481.52$1.9M
Feb 8, 2021TECHSale6,000$385.08$2.3M
Nov 25, 2019TECHSale8,347$219.33$1.8M

SEC reporting-owner ID (CIK) 1492695 · all filings on EDGAR